Twin Focus Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Twin Focus Capital Partners's GILD Position: Q2 2023 in Review
Twin Focus Capital Partners sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 4,269 shares — an estimated $354K sold.
Twin Focus Capital Partners first reported a position in GILD in Q2 2015 and held it in 16 quarters. The position peaked at $502K in Q2 2020. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.
- Twin Focus Capital Partners reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
- Twin Focus Capital Partners sold 4,269 Gilead Sciences shares in Q2 2023, an estimated $354K.
- Twin Focus Capital Partners first reported a position in Gilead Sciences in Q2 2015 and held it in 16 quarters.
- Twin Focus Capital Partners's Gilead Sciences position peaked at $502K in Q2 2020.
- 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.
Based on Twin Focus Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.